Evidence map›Paper›PMID 26407988›Full record

ArticleJournal of genetic counseling2016

Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.

Rosie O'Shea, Marie Meany, Cliona Carroll, Nuala Cody, David Healy, Andrew Green, Sally Ann Lynch

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of genetic counseling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Trial
  2. Article
  3. Article
  4. Article
  5. Alzheimer's Prevention Initiative Generation Program: Development of anAlzheimer's & dementia (New York, N. Y.) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rosie O'SheaDepartment of Clinical Genetics, Our Lady's Hospital for Children, Dublin, Ireland. rosieoshea92@yahoo.com.
Marie MeanyDepartment of Clinical Genetics, Our Lady's Hospital for Children, Dublin, Ireland.
Cliona CarrollDepartment of Clinical Genetics, Our Lady's Hospital for Children, Dublin, Ireland.
Nuala CodyDepartment of Clinical Genetics, Our Lady's Hospital for Children, Dublin, Ireland.
David HealyDepartment of Clinical Genetics, Our Lady's Hospital for Children, Dublin, Ireland.
Andrew GreenDepartment of Clinical Genetics, Our Lady's Hospital for Children, Dublin, Ireland.
Sally Ann LynchDepartment of Clinical Genetics, Our Lady's Hospital for Children, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The traditional model of providing cancer predictive testing services is changing. Many genetic centres are now offering a choice to patients in how they receive their results instead of the typical face-to-face disclosure. In view of this shift in practice and the increasing demand on the ROI cancer predictive testing service, a 2 year retrospective study on patient preference in how to receive a Breast Cancer (BRCA) predictive result was carried out. Results showed that 71.7 % of respondents would have liked to have the option of obtaining their results by telephone or by letter. However, when asked about their actual experience of BRCA predictive results disclosure 40.6 % did still value the face-to-face contact, while 44.9 % would still have preferred to receive results by either post or telephone. No significant difference was found between males and females (p > 0.05) and those who tested negative or positive for the BRCA mutation (p > 0.05) in wanting a choice in how their results were disclosed. While the majority expressed a wish to have a choice in how to receive their results, it is important not to underestimate the value of a face-to-face encounter in these circumstances.

Indexed as

DisclosureGenes, BRCA1Genes, BRCA2Genetic TestingPatient PreferenceBreast NeoplasmsFemaleGenetic CounselingHumansIrelandMaleMutationRetrospective StudiesSurveys and QuestionnairesAlternativeBRCA predictiveResults disclosure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.